Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis-Reference-Cited by-同舟云学术

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

Published:2020-07 Issue: Volume:96 Page:131-135
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Zhao Qianwen,Meng Meng,Kumar Rahul,Wu Yinlian,Huang Jiaofeng,Deng Yunlei,Weng Zhiyuan,Yang Li

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans - Call for a One Health approach;El Zowalaty;One health (Amsterdam, Netherlands),2020

2. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China;Hui;Int J Infect Dis,2020

3. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:343-6.

4. The SARS-CoV-2 outbreak: What we know;Wu;Int J Infect Dis,2020

5. The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis;Zhao;Journal of medical virology,2020

Cited by 394 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of lymphocyte-to-C-reactive protein ratio for predicting clinical outcomes in patients with sepsis in intensive care unit: a retrospective single-center study;Frontiers in Molecular Biosciences;2024-09-13

2. Cellular response in the pathogenesis of COVID-19;COVID-19: An Update;2024-09-01

3. Hematological Conditions Associated with COVID-19: Pathophysiology, Clinical Manifestations, and Therapeutic Approaches;European Journal of Medical and Health Research;2024-09-01

4. Laboratory findings predictive of critical illness in hospitalized COVID-19 patients in Tunisia;F1000Research;2024-08-12

5. Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial;Microorganisms;2024-07-16